World J Gastroenterol (2014) 20(47):1773745.10.3748/wjg.v20.i47.17737 201 YamagataKDaitokuHShimamotoYMatsuzakiHHirotaKIshidaJet alBile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1
It showed~19.7% at 24 weeks at the top dose with no plateau yet
We examined multiple parameters including oxidative stress markers, pro-inflammatory cytokine levels, apoptotic signaling, and neurological function
Nhng diu tr dt im th bn c th s dng 2 ln
Typical treatment schedules include: Initial treatment: frequent injections for severe deficiency Maintenance therapy: injections every 23 months Healthcare professionals must always follow clinical guidelines and patient-specific treatment plans
DSIP is not FDA-approved for any indication, and is not approved in the EU, UK, or other major regulated markets